1.Practice of Opening Operation Pharmacy Management Mode Based on Joint Commission International Ac-creditation
Hongni DONG ; Wen PU ; Jingjing XU ; Liang TENG ; Jianhua WANG
China Pharmacy 2015;(25):3531-3533
OBJECTIVE:To regulate the management of operation drug and promote medication security. METHODS:Based on the relevant principles in the standard of JCI,the practice about establishment of operation pharmacy in our hospital was intro-duced,and it were stated from two aspects which included working mode and effects. RESULTS:The working mode were format-ed by definiting the duties and working flow of pharmacist,anesthetist and liaison man. The establishment of operation pharmacy, which brought operation drugs into the unified management system of our hospital,saved manpower and improved work efficien-cy,refined the management of drugs in all aspects,improved the management of drug safety level,strengthened drug expiration date management,implemented the reporting of adverse drug reactions(event)and collecting of medication(potential)errors. The established mode conformed to the relative standard of JCI including preparation,grant,storage and collection of ADR of drug. CONCLUSIONS:The established drug management of operation pharmacy promotes standardized administration of surgery drug, which guarantees the drug use safety of patients.
2.The impact of lymph node metastatic rate on clinical outcome following131I therapy in patients with papillary thyroid carcinoma
Wen GAO ; Jun LIANG ; Teng ZHAO ; Jiao LI ; Yansong LIN
China Oncology 2016;(1):67-72
Background and purpose:This study aimed to investigate the relationship between lymph node metastatic rate (LR) and response to radioiodine therapy in patients with papillary thyroid carcinoma (PTC).Methods:A total number of 143 PTC patients after radioiodine therapy were included and classified into 4 groups [Ⅰ(0%-10%),Ⅱ(>10%-25%),Ⅲ(>25%-50%),Ⅳ(>50%)] according to the lymph node metastatic rate, and the responses to initial radioiodine therapy after a median follow-up period of 20.7 months were evaluated. They were classiifed into 4 groups [excellent response (ER), indeterminate response (IDR), biochemical incomplete response (BIR), and struc-tural incomplete response (SIR)] according to the guideline proposed by 2015 American Thyroid Association. One-Way analysis of variance,χ2 test and Kruskal-Wallis test were used to evaluate the differences in basic clinicopathological features and clinical responses among the 4 groups. The ROC curve was analyzed to evaluate the clinical value of lymph node metastatic rate for predicting ER and optimal cut-off point.Results:There were no signiifcant differences in gender and T-stage among 4 groups (P>0.05). However,Ⅰ group was signiifcantly older than the other 3 groups (P=0.001). With the increase of lymph node metastatic rate, the number of ER cases decreased, while cases of BIR and SIR generally increased. Compared with the other 3 groups, less cases of ER (27.8%), while more BIR (27.8%) or SIR (11.1%) were observed in groupⅣ (H=18.816,P=0.000). Cut-off value of lymph node involved rate was 52.27%, with a better speciifcity of predicting ER. Area under the ROC curve was 0.668.Conclusion:The higher lymph node metastatic rate in patients with PTC, the worse clinical outcome it could be. A cut-off value of lymph node metastatic rate 52.27% is a speciifc independent predictor for the clinical outcome in PTC patients treated with radioiodine therapy.
3.The relationship between the number of dissected central lymph nodes and clinical outcome in pN1a papillary thyroid carcinoma
Teng ZHAO ; Wen GAO ; Jun LIANG ; Xin LI ; Yansong LIN
China Oncology 2017;27(4):256-261
Background and purpose: Neck lymph node metastasis, most of which presents in central neck compartment, is common in patients with papillary thyroid carcinoma (PTC). The objective of this study was to investigate the relationship between the number of dissected central neck lymph nodes and clinical outcome after radioactive iodine (RAI) ablation in pN1a PTC with no more than 5 lymph nodes involvement. Methods: A total of 167 PTC patients who had 1-5 proven metastatic lymph nodes according to postoperative pathological diagnosis were retrospectively analyzed, all of whom underwent total or near total thyroidectomy and central lymph node dissection. After a median follow-up period of 26 months, the clinical outcome of each patient was evaluated as excellent response (ER), indeterminate response (IDR), bio-chemical incomplete response (BIR), or structural incomplete response (SIR) according to the new American Thyroid As-sociation guidelines. The accumulative ER rate (ERn) was calculated in patients with different numbers of dissected lymph nodes (ERn was defined as the proportion of patients who achieved ER with the dissected lymph node number of ≤n). The relationship between the number of dissected central neck lymph nodes and ERn were investigated. Results: As the increase in the number of dissected central neck lymph nodes,there was also an overall increase in ERn, especially when n rose from 1 to 10. The values of ER1, ER5, ER10 and ER30 were 25.0%, 66.7%, 74.7% and 79.1%, respectively. Besides, the proportion of patients who achieved ER was higher in those with 10 or more dissected lymph nodes than in those with less than 10 (85.7% vs 73.3%, P=0.05). In the multivariate logistic regression analysis, both the dissected central lymph node number of ≥10 (OR=2.720, 95%CI: 1.052-7.033, P=0.039) and the level of preablation stimulated thyroglobulin (OR=0.955, 95%CI: 0.926-0.984, P=0.003) were shown to contribute independently to ER. Conclusion: As the increas-ing number of dissected central neck lymph nodes, the percentage of pN1a PTC patients that achieved ER after RAI ablation generally rises. In pN1a PTC patients with no more than 5 lymph nodes involvement, a central compartment dissection with 10 or more lymph nodes might help them achieve ER after RAI ablation.
4.Recent advances in diagnosis of flat lesions of urinary bladder.
Liang CHENG ; Jia-wen XU ; Xiao-Dong TENG
Chinese Journal of Pathology 2010;39(9):577-581
Antigens, CD20
;
metabolism
;
Carcinoma in Situ
;
classification
;
diagnosis
;
metabolism
;
pathology
;
Diagnosis, Differential
;
Humans
;
Hyaluronan Receptors
;
metabolism
;
Hyperplasia
;
Precancerous Conditions
;
diagnosis
;
metabolism
;
pathology
;
Tumor Suppressor Protein p53
;
metabolism
;
Urinary Bladder
;
metabolism
;
pathology
;
Urinary Bladder Neoplasms
;
classification
;
diagnosis
;
metabolism
;
pathology
;
Urothelium
;
metabolism
;
pathology
5.Study on optineurin gene polymorphism in Chinese patients with primary open angle glaucoma
Si-ying, LIANG ; Li-na, HUANG ; Fang-wei, YING ; Jing, HE ; Teng-liang, WEN
Chinese Journal of Experimental Ophthalmology 2013;31(9):863-866
Background Primary open angle glaucoma(POAG) is a common type of glaucoma.It has been well known that a lot of factors are associated with the pathogenesis of POAG,but genetic factor plays a critical role.Optineurin (OPTN)gene is the second confirmed POAG-relevant gene,and screening its mutation in the population contribute to the deeply understanding of the pathogenesis of POAG.Objective The present study was to investigate the association between sequence variants of OPTN gene and POAG in Chinese patients.Methods DNA was isolated from peripheral blood of 100 POAG patients and 60 cataract individuals.The coding exons of OPTN gene were amplified by PCR.PCR products were then sequenced directly to assay the variants and contrasted to original sequence in GenBank.This study was approved by the Ethical Committee of Shenzhen Eye Hospital.All the subjects signed the written inform consent.Results A case-controlled study was designed.The mean intraocular pressure (IOP)of the POAG patients was (29.0±6.5)mmHg,and that of the cataract patients was (13.7 ±2.4)mmHg.Variant of synonymous coding T34T was found in 60 POAG patients.Genetic type frequencies of AA,GA and GG were 10%,50% and 40% in the POAG patients,and those of cataract patients were 0,25% and 75% respectively,showing significant difference between them (x2 =20.416,P =0.000).The allele frequencies of A and G were 35% and 65% in the POAG patients,and those of cataract patients were 12.5% and 87.5%,with a statistically significant difference (x2 = 19.464,P =0.000).The sequence changes of non-synonymous coding variants (M98K,691-692insA G,R545Q,H486R) were also found in both POAG and cataract patients,but no significant difference was seen in the genetype and allele frequencies between two groups (P>0.05).Conclusions No obvious association of OPTN gene variant with POAG is verified.The variant of T34T maybe increase the risk of POAG.
6.Recent advances in diagnosis of malignant soft tissue tumor of urinary bladder.
Liang CHENG ; Wen-bin HUANG ; Xiao-dong TENG ; Jia-wen XU ; Shao-bo ZHANG
Chinese Journal of Pathology 2010;39(2):126-130
Diagnosis, Differential
;
Hemangiopericytoma
;
metabolism
;
pathology
;
Hemangiosarcoma
;
metabolism
;
pathology
;
Histiocytoma, Malignant Fibrous
;
metabolism
;
pathology
;
Humans
;
Immunohistochemistry
;
Leiomyosarcoma
;
metabolism
;
pathology
;
Nerve Sheath Neoplasms
;
metabolism
;
pathology
;
Neuroectodermal Tumors, Primitive
;
metabolism
;
pathology
;
Rhabdoid Tumor
;
metabolism
;
pathology
;
Rhabdomyosarcoma
;
metabolism
;
pathology
;
Soft Tissue Neoplasms
;
metabolism
;
pathology
;
Urinary Bladder
;
metabolism
;
pathology
7.Clinical applications of molecular biomarkers in urothelial carcinoma of bladder.
Liang CHENG ; Jia-wen XU ; Jia-jia HE ; Jing ZHAO ; Xiao-dong TENG
Chinese Journal of Pathology 2011;40(10):714-717
Antineoplastic Combined Chemotherapy Protocols
;
therapeutic use
;
Basigin
;
analysis
;
Biomarkers, Tumor
;
analysis
;
genetics
;
Carcinoma, Transitional Cell
;
drug therapy
;
genetics
;
metabolism
;
Gene Expression Profiling
;
Humans
;
In Situ Hybridization, Fluorescence
;
Inhibitor of Apoptosis Proteins
;
analysis
;
Mutation
;
Neoplasm Recurrence, Local
;
metabolism
;
Nuclear Proteins
;
analysis
;
Receptor, Fibroblast Growth Factor, Type 3
;
analysis
;
genetics
;
Tumor Suppressor Protein p53
;
analysis
;
genetics
;
Urinary Bladder Neoplasms
;
drug therapy
;
genetics
;
metabolism
8.The relationship between the rate of involved lymph nodes and distant metastasis in papillary thyroid carcinoma
Wen GAO ; Jun LIANG ; Xiaoyi LI ; Teng ZHAO ; Chen WANG ; Yansong LIN
China Oncology 2017;27(1):26-30
Background and purpose:Lymph node metastasis commonly occurs in papillary thyroid carcino-ma (PTC). The object of this study was to investigate the relationship between the rate of involved lymph nodes (LR) and distant metastasis (DM) in PTC, and its potential value in predicting the risk of DM.Methods:PTC patients were divided into two groups as M0 (121 cases) and M1 (41 cases) according to the presence of distant metastases or not. The t-text andχ2 test were used to evaluate the statistical differences in basic clinicopathological features between the two groups. Multivariate analysis was used to quantify LR as an independent factor of DM. The receiver operating charac-teristic (ROC) curve was employed to evaluate the clinical value of LR and the number of involved lymph node (LNs) for predicting DM and optimal cut-off point respectively. The cumulative risk of distant metastasis curves according to the LR and LNs status were constructed with the Kaplan-Meier method, and the Log-rank test was used to compare these curves.Results:There were no statistical differences in age and multifocality between two groups (P>0.05), while signiifcant differences in gender, extrathyroidal invasion and tumor size were observed. LR is an independent indicator for predicting DM (OR=1.133,P=0.000). An increase in LR was signiifcantly associated with DM. Patients with more than 15 involved LNs had the steepest increasing pattern in the cumulative risk of DM compared with those who had less than 15 involved LN (P=0.002).Conclusion:LR may be an independent predictive marker for distant metastases in PTC, and its combination with LNs might better predict the risk of DM.
9.Congenital neurocutaneous melanosis.
Li-kang LUO ; Liang-hong TENG ; Jian ZHAO ; Su-ying ZHOU ; Wen-xing XU ; Juan-mei LI
Chinese Journal of Pathology 2005;34(4):246-247
Antigens, Neoplasm
;
Brain
;
metabolism
;
pathology
;
Humans
;
Infant, Newborn
;
Lung
;
metabolism
;
pathology
;
Male
;
Melanoma-Specific Antigens
;
Melanosis
;
complications
;
congenital
;
metabolism
;
pathology
;
Neoplasm Proteins
;
metabolism
;
Neurocutaneous Syndromes
;
complications
;
congenital
;
metabolism
;
pathology
;
S100 Proteins
;
metabolism
;
Skin
;
metabolism
;
pathology
10.Histologic variants of prostate cancer.
Liang CHENG ; Jia-wen XU ; Xiao-dong TENG
Chinese Journal of Pathology 2009;38(7):495-498
Adenocarcinoma
;
pathology
;
Carcinoma, Acinar Cell
;
pathology
;
Carcinoma, Adenosquamous
;
pathology
;
Carcinoma, Basal Cell
;
pathology
;
Carcinoma, Endometrioid
;
pathology
;
Carcinoma, Small Cell
;
pathology
;
Carcinoma, Squamous Cell
;
pathology
;
Carcinosarcoma
;
pathology
;
Humans
;
Immunohistochemistry
;
Male
;
Prostatic Neoplasms
;
classification
;
pathology